Tauroursodeoxycholic-d5 Acid Cas14605-22-2 Supplier

Cas.No.14605-22-2 

Chemical NameTauroursodeoxycholic acidMDLMFCD00069496MolFormulaC26H45NO6SMolWeight499.708Purity99%

                                             

  Function

UDCA is produced in several countries for the treatment of gallstones and liver cirrhosis. It is not approved by the Food and Drug Administration, in the U.S. while UDCA is approved in the United States for the treatment of primary biliary cirrhosis Ongoing research is finding TUDCA has diminishing apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.

 Our services

1. Supply top quality products with a reasonable price.

2. Arrange the orders and shipping with your requests on time, According to the different countries export policy provide complete customs clearance documents.

3. Samples can be arranged for testing and Unconditional assume responds.

4. Provide a price trend, ensure the clients can know about  marketing informations in time.

Packing and Shipping: